Lycium barbarum glycopeptide attenuates orthodontic force–induced alveolar bone loss by activating ATG4D-mediated autophagy

Puntos clave

• Glycopeptide treatment significantly reduces alveolar bone loss due to orthodontic force, preserving bone structure.
• The key metric shows a reduction in bone loss rates, improving long-term orthodontic outcomes.
• Analysis utilizes autophagy mechanisms mediated by ATG4D to explain the therapeutic effects of glycopeptide.
• Supports the idea that natural compounds can provide novel strategies for managing orthodontic-related bone loss.